Author

V. Dudeja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Saluja· 3 shared K. Kesh· 3 shared R. Hadad· 3 shared S. Banerjee· 3 shared V. K. Gupta· 3 shared B. C. Durden· 2 shared B. Giri· 2 shared N. S. Sharma· 2 shared

Activity by Year

2018-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Saluja

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression, remodels extracellular matrix and sensitizes to anti-PD1 therapy.

N. S. Sharma, V. K. Gupta, V. T. Garrido, R. Hadad, B. C. Durden, K. Kesh, B. Giri, A. Ferrantella, V. Dudeja, A. Saluja, S. Banerjee

This study shows that targeting the HBP metabolic node in pancreatic cancer with DON reduces tumor growth, remodels the ECM, and enhances response to anti-PD1 therapy.

bioRxiv · Sep 18, 2019Cancer Biology

Long non-coding RNA GAS5 acts as proliferation brakes in CD133+ cells responsible for tumor recurrence

N. S. Sharma, P. Gnamlin, B. C. Durden, V. K. Gupta, K. Kesh, V. Garrido, R. Hadad, V. Dudeja, A. Saluja, S. Banerjee

This study shows GAS5 regulates quiescence and growth arrest in CD133+ cells, which drive tumor recurrence in pancreatic cancer by inhibiting cell cycle progression and altering metabolic pathways.

bioRxiv · Jun 13, 2019Cancer Biology

O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer

N. Sharma, V. K. Gupta, P. Dauer, K. Kesh, R. Hadad, B. Giri, A. Chandra, V. Dudeja, C. Slawson, S. Banerjee, S. M. Vickers, A. Saluja, S. Banerjee

This study shows that O-GlcNAc modification of Sox2 stabilizes the protein and enhances self-renewal in pancreatic cancer, with targeting OGT reducing tumor burden.

bioRxiv · Jun 12, 2018Cancer Biology